DDX3X and colorectal carcinoma: To estimate the working concentration of RK33 in CRC cells and explore the effect of DDX3 loss-of-function on the MAPK pathway, we treated SW480 cells with RK33 in a serial concentration gradient for 12 h and extracted total proteins for western blot analysis.